Medallion Wealth Advisors’s Johnson & Johnson JNJ Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$1.96M Buy
8,014
+1,033
+15% +$241K 0.64% 36
2025
Q4
$1.44M Buy
6,981
+475
+7% +$93.9K 0.49% 54
2025
Q3
$1.21M Buy
6,506
+18
+0.3% +$3.08K 0.43% 56
2025
Q2
$1.01M Buy
6,488
+319
+5% +$49K 0.39% 65
2025
Q1
$971K Buy
6,169
+274
+5% +$42.9K 0.44% 51
2024
Q4
$896K Buy
+5,895
New +$914K 0.44% 52

Other funds holding JNJ

Medallion Wealth Advisors's JNJ Position: Q1 2026 in Review

Medallion Wealth Advisors increased its Johnson & Johnson (JNJ) stake by 15% in Q1 2026, buying an estimated $241K and bringing the position to 8,014 shares worth $1.96M. The position accounts for 0.64% of the portfolio, ranked #36.

Medallion Wealth Advisors first reported a position in JNJ in Q4 2024 and has held it in 6 quarters since. 4,616 funds tracked by Wall St. Rank hold JNJ as of Q1 2026.

  • Medallion Wealth Advisors held 8,014 shares of Johnson & Johnson worth $1.96M as of Q1 2026.
  • Medallion Wealth Advisors bought 1,033 Johnson & Johnson shares in Q1 2026, an estimated $241K.
  • Johnson & Johnson made up 0.64% of Medallion Wealth Advisors's portfolio in Q1 2026, its #36 holding.
  • Medallion Wealth Advisors first reported a position in Johnson & Johnson in Q4 2024 and has held it in 6 quarters since.
  • 4,616 funds tracked by Wall St. Rank held Johnson & Johnson as of Q1 2026.

Based on Medallion Wealth Advisors's 13F filing for Q1 2026, filed 24 Apr 2026.